Literature DB >> 7507495

The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology.

K Gerritse1, C Deen, M Fasbender, R Ravid, W Boersma, E Claassen.   

Abstract

Irrespective of the large body of literature on the putative role of antibodies in the development of multiple sclerosis (MS), the detection of specific antibody-forming B cells (AFCs) in the central nervous system (CNS) tissues has not been described. In this study we show that autoantigen-specific AFCs can be found in CSN tissue sections of MS patients. Applying a newly developed myelin basic protein (MBP)-enzyme conjugate technique, we have detected MBP-specific AFCs in autopsy periventricular white matter and cerebellum tissue sections of MS patients. We demonstrated the presence of MBP-specific AFCs in CNS tissue sections in five out of 12 MS patients. No MBP-specific AFCs were detected in CNS tissue sections of 11 patients with other neurological diseases, such as Parkinson's and Alzheimer's disease, or in brain tissue sections of eight deceased persons without neurological diseases. In MS patients, anti-MBP AFCs were present in brain tissue sections both with and without plaques. The proportion of MBP-specific AFCs in some of the MS patient brain tissues reached over 50% of all AFCs. The high relative frequency of the anti-MBP AFCs and their localization in periventricular white matter and cerebellum of MS patients only, suggests that anti-MBP AFCs represent a cell population, which could play an important role in MS immunopathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507495     DOI: 10.1016/0165-5728(94)90191-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?

Authors:  H Lassmann; K Vass
Journal:  Springer Semin Immunopathol       Date:  1995

Review 3.  Multiple sclerosis: an altered immune response or an altered stress response?

Authors:  J M van Noort
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

4.  Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens.

Authors:  A Matsuo; G C Lee; K Terai; K Takami; W F Hickey; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  K Gerritse; J D Laman; R J Noelle; A Aruffo; J A Ledbetter; W J Boersma; E Claassen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

6.  CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS.

Authors:  Shuen-Ing Tschen; Stephen A Stohlman; Chandran Ramakrishna; David R Hinton; Roscoe D Atkinson; Cornelia C Bergmann
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

7.  Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea.

Authors:  Jane L Zhu; Ricardo T Paniagua; Henry W Chen; Stephanie Florez-Pollack; Elaine Kunzler; Noelle Teske; Yevgeniya Byekova Rainwater; Quan-Zhen Li; Gregory A Hosler; Wenhao Li; Denise M O Ramirez; Nancy L Monson; Heidi T Jacobe
Journal:  J Transl Med       Date:  2022-01-24       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.